Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$31,138,256
+$11,415,119 QoQ
Shares Held
1,293,117
+84.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#224
of 2,821 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EXCHANGE TRADED CONCEPTS, LLC holds $267,487,423 across 11 Drug Manufacturers - General names. PFE ranks #5 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
47,128 | $56,526,740 | |
| 2 | JNJ |
Johnson & Johnson
|
196,257 | $49,843,389 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
649,566 | $37,427,991 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
266,845 | $33,713,195 | |
| 5 | PFE |
Pfizer Inc
This page
|
1,293,117 | $31,138,256 | |
| 6 | ABBV |
AbbVie Inc.
|
105,544 | $26,559,091 | |
| 7 | MRK |
Merck & Co., Inc.
|
113,353 | $14,565,860 | |
| 8 | AMGN |
Amgen Inc
|
22,775 | $8,247,282 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,138,256 | 1,293,117 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $19,723,137 | 702,391 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $27,439,251 | 1,101,978 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $29,627,836 | 1,162,788 | Shares | Other | 2025-10-14 | |
| 2025-06-30 | $29,101,669 | 1,200,564 | Shares | Other | 2025-07-10 | |
| 2025-03-31 | $15,022,361 | 592,832 | Shares | Other | 2025-04-17 | |
| 2024-12-31 | $2,022,911 | 76,250 | Shares | Other | 2025-01-21 | |
| 2024-09-30 | $2,002,011 | 69,178 | Shares | Other | 2024-10-10 | |
| 2024-06-30 | $892,141 | 31,885 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $65,823 | 2,372 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $93,222 | 3,238 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $11,775 | 355 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $3,088,712 | 84,207 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $14,342,628 | 351,535 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $13,745,027 | 268,248 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $11,394,185 | 260,379 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $23,742,715 | 452,846 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $25,374,340 | 490,136 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $21,046,010 | 356,410 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $18,989,517 | 441,514 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $10,904,885 | 278,470 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $10,110,235 | 279,057 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $8,558,288 | 232,499 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $12,586,913 | 342,968 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $7,860,957 | 240,396 | Shares | Sole | 2020-07-15 | |
| No filing history on record for this holder in this stock. | ||||||